Epizyme reported $-35744000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Amarin AMRN:US $ -69.96M 38.39M
Amgen AMGN:US $ 1317M 159M
Avrobio Inc AVRO:US $ -28054000 1.78M
Biogen BIIB:US $ 1058M 754.2M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Daiichi Sankyo 4568:JP Y 18852M 46197M
Eisai 4523:JP Y 26898M 39301M
Epizyme EPZM:US $ -35.74M 19.76M
Exelixis EXEL:US $ 70.67M 2.1M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Glaxosmithkline GSK:US $ 838M 964M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Merk MRK:US $ 3944M 366M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 1694M 528M
Novartis NVS:US $ 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Spectrum Pharmaceuticals SPPI:US $ -29.05M 13.61M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
Xencor XNCR:US $ -33.98M 57.57M